Agency Forms Undergoing Paperwork Reduction Act Review, 66028-66029 [2016-23073]
Download as PDF
<![CDATA[
66028
Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–23074 Filed 9–23–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Project
Centers for Disease Control and
Prevention
[30Day–16–1011]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
mstockstill on DSK3G9T082PROD with NOTICES
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Emergency Epidemic Investigation
Data Collections (OMB Control Number
0920–1011, Expiration 03–31–2017)—
Extension — Division of Scientific
Education and Professional
Development, Center for Surveillance,
Education, and Laboratory Services,
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC previously conducted Emergency
Epidemic Investigations (EEIs) under
OMB Control Number 0920–0008. In
2013, CDC received OMB approval
(OMB Control Number 0920–1011) for a
new OMB generic clearance for a threeyear period to collect vital information
during EEIs in response to urgent
outbreaks or events (i.e., natural,
biological, chemical, nuclear,
radiological) characterized by
undetermined agents, undetermined
sources, undetermined transmission, or
undetermined risk factors. CDC seeks
OMB approval for an extension of this
generic clearance (OMB control number
0920–1011) for a three-year period.
Supporting effective emergency
epidemic investigations is one of the
most important ways that CDC protects
the health of the public. CDC is
frequently called upon to conduct EEIs
at the request of local, state, or
international health authorities seeking
support to respond to urgent outbreaks
or urgent public health-related events.
In response to external partner requests,
CDC provides necessary epidemiologic
support to identify the agents, sources,
modes of transmission, or risk factors to
effectively implement rapid prevention
and control measures to protect the
public’s health. Data collection is a
critical component of the epidemiologic
support provided by CDC; data are
analyzed to determine the agents,
sources, modes of transmission, or risk
factors so that effective prevention and
control measures can be implemented.
During an unanticipated outbreak or
event, immediate action by CDC is
necessary to minimize or prevent public
harm. The legal justification for EEIs are
found in the Public Health Service Act
(42 U.S.C. Sec. 301[241](a).
Successful investigations are
dependent on rapid and flexible data
collection that evolves during the
investigation and is customized to the
unique circumstances of each outbreak
or event. Data collection elements will
be those necessary to identify the
agents, sources, mode of transmission,
or risk factors. Examples of potential
data collection methods include
telephone or face-to-face interview;
email, web or other type of electronic
questionnaire; paper-and-pencil
questionnaire; focus groups; medical
record review; laboratory record review;
collection of clinical samples; and
environmental assessment. Respondents
will vary depending on the nature of the
outbreak or event; examples of potential
respondents include health care
professionals, patients, laboratorians,
and the general public. Participation in
EEIs is voluntary and there are no
anticipated costs to respondents other
than their time. CDC will use the
information gathered during EEIs to
rapidly identify and effectively
implement measures to minimize or
prevent public harm.
CDC projects 60 EEIs in response to
outbreaks or events characterized by
undetermined agents, undetermined
sources, undetermined transmission, or
undetermined risk factors annually. The
projected average number of
respondents is 200 per EEI, for a total
of 12,000 respondents. CDC estimates
the average burden per response is 0.5
hours and each respondent will be
asked to respond once. Therefore, the
total estimated annual burden hours are
6,000. These estimates are based on the
reported burden for EEIs that have been
performed during the previous two
years.
OMB approval is requested for three
years. Participation is based on previous
Emergency Epidemic Investigations.
There are no costs to respondents.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Emergency Epidemic Investigation Participants.
Emergency Epidemic Investigation Data Collection Instruments.
VerDate Sep<11>2014
19:40 Sep 23, 2016
Jkt 238001
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
12,000
E:\FR\FM\26SEN1.SGM
26SEN1
Number of
responses per
respondent
1
Average
burden per
response
(in hrs.)
30/60
Federal Register / Vol. 81, No. 186 / Monday, September 26, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–23073 Filed 9–23–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES (HHS)
Centers for Disease Control and
Prevention (CDC)
Breast and Cervical Cancer Early
Detection and Control Advisory
Committee (BCCEDCAC): Notice of
Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the charter
for the Breast and Cervical Cancer Early
Detection and Control Advisory
Committee, Department of Health and
Human Services, has been renewed for
a 2-year period through September 12,
2018.
For information, contact Ms. Jameka
Blackmon, Designated Federal Officer,
BCCEDCAC, CDC, 1600 Clifton Road
NE., M/S K57, Atlanta, Georgia, 30329,
telephone (770) 488–4740; fax (770)
488–3230.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–23057 Filed 9–23–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK3G9T082PROD with NOTICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Notice of Charter
Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the charter
for the Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel, Centers for Disease
VerDate Sep<11>2014
19:40 Sep 23, 2016
Jkt 238001
Control and Prevention, Department of
Health and Human Services, has been
renewed for a 2-year period through
September 18, 2018.
For information, contact M. Chris
Langub, Ph.D., Designated Federal
Officer, Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel, Centers for Disease
Control and Prevention, Department of
Health and Human Services, 1600
Clifton Road NE., Mailstop K48, Atlanta,
Georgia 30329, telephone (770) 488–
3585 or fax (770) 488–4887.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–23054 Filed 9–23–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
PAR 13–129, Occupational Safety and
Health Research, NIOSH Member
Conflict Review.
Time and Date: 1:00 p.m.–5:00 p.m.,
EDT, October 20, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘PAR 13–129, NIOSH Member Conflict
Review.’’
Contact Person for More Information:
Nina Turner, Ph.D., Scientific Review
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
66029
Officer, NIOSH, CDC, 1095 Willowdale
Road, Mailstop G905, Morgantown,
West Virginia 26506, Telephone: (304)
285–5976.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2016–23056 Filed 9–23–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee.
Time and Date:
8:00 a.m.–6:00 p.m., EDT, October 19,
2016
8:00 a.m.–3:30 p.m., EDT, October 20,
2016
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton
Road NE., Building 19, Kent ‘‘Oz’’
Nelson Auditorium, Atlanta, Georgia
30329.
Status: Open to the public, limited
only by the space available. Time will
be available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipt is
October 11, 2016. All written comments
must contain the name, address, and
organizational affiliation of the speaker,
as well as the topic being addressed.
Written comments should not exceed
one single-spaced typed page in length
and delivered in 3 minutes or less.
Please note that the public comment
period may end before the time
indicated, following the last call for
comments. Members of the public who
wish to provide public comments
should plan to attend the public
comment session at the start time listed.
Written comments received in advance
E:\FR\FM\26SEN1.SGM
26SEN1
]]>Agencies
[Federal Register Volume 81, Number 186 (Monday, September 26, 2016)]
[Notices]
[Pages 66028-66029]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23073]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-1011]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Emergency Epidemic Investigation Data Collections (OMB Control
Number 0920-1011, Expiration 03-31-2017)--Extension -- Division of
Scientific Education and Professional Development, Center for
Surveillance, Education, and Laboratory Services, Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC previously conducted Emergency Epidemic Investigations (EEIs)
under OMB Control Number 0920-0008. In 2013, CDC received OMB approval
(OMB Control Number 0920-1011) for a new OMB generic clearance for a
three-year period to collect vital information during EEIs in response
to urgent outbreaks or events (i.e., natural, biological, chemical,
nuclear, radiological) characterized by undetermined agents,
undetermined sources, undetermined transmission, or undetermined risk
factors. CDC seeks OMB approval for an extension of this generic
clearance (OMB control number 0920-1011) for a three-year period.
Supporting effective emergency epidemic investigations is one of
the most important ways that CDC protects the health of the public. CDC
is frequently called upon to conduct EEIs at the request of local,
state, or international health authorities seeking support to respond
to urgent outbreaks or urgent public health-related events. In response
to external partner requests, CDC provides necessary epidemiologic
support to identify the agents, sources, modes of transmission, or risk
factors to effectively implement rapid prevention and control measures
to protect the public's health. Data collection is a critical component
of the epidemiologic support provided by CDC; data are analyzed to
determine the agents, sources, modes of transmission, or risk factors
so that effective prevention and control measures can be implemented.
During an unanticipated outbreak or event, immediate action by CDC is
necessary to minimize or prevent public harm. The legal justification
for EEIs are found in the Public Health Service Act (42 U.S.C. Sec.
301[241](a).
Successful investigations are dependent on rapid and flexible data
collection that evolves during the investigation and is customized to
the unique circumstances of each outbreak or event. Data collection
elements will be those necessary to identify the agents, sources, mode
of transmission, or risk factors. Examples of potential data collection
methods include telephone or face-to-face interview; email, web or
other type of electronic questionnaire; paper-and-pencil questionnaire;
focus groups; medical record review; laboratory record review;
collection of clinical samples; and environmental assessment.
Respondents will vary depending on the nature of the outbreak or event;
examples of potential respondents include health care professionals,
patients, laboratorians, and the general public. Participation in EEIs
is voluntary and there are no anticipated costs to respondents other
than their time. CDC will use the information gathered during EEIs to
rapidly identify and effectively implement measures to minimize or
prevent public harm.
CDC projects 60 EEIs in response to outbreaks or events
characterized by undetermined agents, undetermined sources,
undetermined transmission, or undetermined risk factors annually. The
projected average number of respondents is 200 per EEI, for a total of
12,000 respondents. CDC estimates the average burden per response is
0.5 hours and each respondent will be asked to respond once. Therefore,
the total estimated annual burden hours are 6,000. These estimates are
based on the reported burden for EEIs that have been performed during
the previous two years.
OMB approval is requested for three years. Participation is based
on previous Emergency Epidemic Investigations. There are no costs to
respondents.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hrs.)
----------------------------------------------------------------------------------------------------------------
Emergency Epidemic Investigation Emergency Epidemic 12,000 1 30/60
Participants. Investigation Data
Collection Instruments.
----------------------------------------------------------------------------------------------------------------
[[Page 66029]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-23073 Filed 9-23-16; 8:45 am]
BILLING CODE 4163-18-P
